Comparing the Efficacy of Probiotic Plus Antibiotic with the Antibiotic Therapy Alone on the Recurrence of Bacterial Vaginosis

Overview

Journal Pak J Med Sci

Date 2025 Jan 27

PMID 39867779

Authors

Saima Ashraf

Ammara Haroon

Asiya Fayyaz

Affiliations

Soon will be listed here.

Abstract

Objective: To compare the efficacy of a probiotic plus antibiotic with antibiotic therapy alone for the prevention of the recurrence of bacterial vaginosis.

Method: A Randomized control trial was conducted in the Gynecological Department of Nishtar Hospital, Multan, between July 2022 and June 2023. One hundred and twenty (N=120) women with bacterial vaginosis, all cured with metronidazole, were enrolled and randomized. In Group-A, Probiotics were administered once a day for 14 days following antibiotic treatment (Tab Metronidazole 400mg, three times a day for seven days). In Group-B, only oral antibiotics were given. The patients were followed up in four visits for five months for bacterial vaginosis recurrence (responders, partial responders, non-responders, and drop-outs) using Amsel criteria by vaginal swabs. All the data was collected on a structured Performa.

Results: The mean age of enrolled 120 women was 32.28±2.58, and 111(92.5%) were married. Of 120 enrolled women, 8 (6.7%) were dropped out. Evaluating the recurrence rate, the probiotic group (n=57) had fewer recurrences than the placebo (n=55) (8.9% vs 21.4%, p-value <0.05). Group-A had a better responder rate at five months of follow-up than the placebo group (39.2% vs. 25.8%) (RR 0.31, 95%CI: 0.1450-0.7998, -Value <0.05). Comparing the effect of probiotics on the components of the Amsel criteria, only vaginal discharge had a statistically significant reduction by using probiotics plus antibiotics (-value≤0.05).

Conclusion: This trial showed that probiotics plus antibiotics significantly reduced bacterial vaginosis recurrences than antibiotics alone.

References

Nasioudis D, Linhares I, Ledger W, Witkin S . Bacterial vaginosis: a critical analysis of current knowledge. BJOG. 2016; 124(1):61-69. DOI: 10.1111/1471-0528.14209. View

Abou Chacra L, Fenollar F, Diop K . Bacterial Vaginosis: What Do We Currently Know?. Front Cell Infect Microbiol. 2022; 11:672429. PMC: 8805710. DOI: 10.3389/fcimb.2021.672429. View

Bhakta V, Aslam S, Aljaghwani A . Bacterial vaginosis in pregnancy: prevalence and outcomes in a tertiary care hospital. Afr J Reprod Health. 2021; 25(1):49-55. DOI: 10.29063/ajrh2021/v25i1.6. View

Cherpes T, Hillier S, Meyn L, Busch J, Krohn M . A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology. Sex Transm Dis. 2007; 35(1):78-83. DOI: 10.1097/OLQ.0b013e318156a5d0. View

Bitew A, Mengist A, Belew H, Aschale Y, Reta A . The Prevalence, Antibiotic Resistance Pattern, and Associated Factors of Bacterial Vaginosis Among Women of the Reproductive Age Group from Felege Hiwot Referral Hospital, Ethiopia. Infect Drug Resist. 2021; 14:2685-2696. PMC: 8286113. DOI: 10.2147/IDR.S305329. View

Wang Z, Zhang L, Zhao M, Wang Y, Bai H, Wang Y . Deep Neural Networks Offer Morphologic Classification and Diagnosis of Bacterial Vaginosis. J Clin Microbiol. 2020; 59(2). PMC: 8111127. DOI: 10.1128/JCM.02236-20. View

Witkin S, Linhares I . Why do lactobacilli dominate the human vaginal microbiota?. BJOG. 2017; 124(4):606-611. DOI: 10.1111/1471-0528.14390. View

Rostok M, Hutt P, Roop T, Smidt I, Stsepetova J, Salumets A . Potential vaginal probiotics: safety, tolerability and preliminary effectiveness. Benef Microbes. 2019; 10(4):385-393. DOI: 10.3920/BM2016.0123. View

Zhang Y, Lyu J, Ge L, Huang L, Peng Z, Liang Y . Probiotic GR-1 and RC-14 as an Adjunctive Treatment for Bacterial Vaginosis Do Not Increase the Cure Rate in a Chinese Cohort: A Prospective, Parallel-Group, Randomized, Controlled Study. Front Cell Infect Microbiol. 2021; 11:669901. PMC: 8291149. DOI: 10.3389/fcimb.2021.669901. View

10.

Mulinganya G, De Vulder A, Bisimwa G, Boelens J, Claeys G, De Keyser K . Prevalence, risk factors and adverse pregnancy outcomes of second trimester bacterial vaginosis among pregnant women in Bukavu, Democratic Republic of the Congo. PLoS One. 2021; 16(10):e0257939. PMC: 8544863. DOI: 10.1371/journal.pone.0257939. View

11.

Tomas M, Palmeira-de-Oliveira A, Simoes S, Martinez-de-Oliveira J, Palmeira-de-Oliveira R . Bacterial vaginosis: Standard treatments and alternative strategies. Int J Pharm. 2020; 587:119659. DOI: 10.1016/j.ijpharm.2020.119659. View

12.

Chen R, Li R, Qing W, Zhang Y, Zhou Z, Hou Y . Probiotics are a good choice for the treatment of bacterial vaginosis: a meta-analysis of randomized controlled trial. Reprod Health. 2022; 19(1):137. PMC: 9195231. DOI: 10.1186/s12978-022-01449-z. View

13.

Bradshaw C, Sobel J . Current Treatment of Bacterial Vaginosis-Limitations and Need for Innovation. J Infect Dis. 2016; 214 Suppl 1:S14-20. PMC: 4957510. DOI: 10.1093/infdis/jiw159. View

14.

Muthusamy S, Varghese J, Raveendran V, Ezilarasan K, Easow J . Evaluation of interobserver reliability of Nugent score for diagnosis of bacterial vaginosis. Indian J Sex Transm Dis AIDS. 2019; 39(2):120-123. PMC: 6298156. DOI: 10.4103/ijstd.IJSTD_98_16. View

15.

Armstrong E, Hemmerling A, Miller S, Burke K, Newmann S, Morris S . Metronidazole treatment rapidly reduces genital inflammation through effects on bacterial vaginosis-associated bacteria rather than lactobacilli. J Clin Invest. 2022; 132(6). PMC: 8920324. DOI: 10.1172/JCI152930. View

16.

Reid G . Is bacterial vaginosis a disease?. Appl Microbiol Biotechnol. 2017; 102(2):553-558. DOI: 10.1007/s00253-017-8659-9. View

17.

Armstrong E, Hemmerling A, Miller S, Burke K, Newmann S, Morris S . Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo-controlled trial. Lancet Microbe. 2022; 3(6):e435-e442. PMC: 9188188. DOI: 10.1016/S2666-5247(22)00043-X. View

18.

Coudray M, Madhivanan P . Bacterial vaginosis-A brief synopsis of the literature. Eur J Obstet Gynecol Reprod Biol. 2020; 245:143-148. PMC: 6989391. DOI: 10.1016/j.ejogrb.2019.12.035. View

19.

Yuk Y, Choi J, Kim J . Age and sex trends of infection in patients with sexually transmitted infections in Korea. Iran J Microbiol. 2022; 13(6):779-784. PMC: 8816691. DOI: 10.18502/ijm.v13i6.8079. View

20.

Majigo M, Kashindye P, Mtulo Z, Joachim A . Bacterial vaginosis, the leading cause of genital discharge among women presenting with vaginal infection in Dar es Salaam, Tanzania. Afr Health Sci. 2021; 21(2):531-537. PMC: 8568229. DOI: 10.4314/ahs.v21i2.7. View